Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib. Ding J, Yao Y, Huang G, Wang X, et al. Cancer Lett 2020 Jan 29. pii: S0304-3835(20)30046.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ding J, Yao Y, Huang G, Wang X, et al. Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib. Cancer Lett 2020 Jan 29. pii: S0304-3835(20)30046.
PMID: 32006616